Quizartinib (Vanflyta,Zagudx)

Quizartinib specifically targets the FLT3-ITD mutant protein, blocking downstream MAPK/ERK, PI3K/AKT, and STAT5 signaling pathways, thereby inhibiting leukemia cell proliferation and inducing apoptosis.

17.7mg*28tablets
26.5mg*28tablets

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Quizartinib Medication Guide

Quizartinib(Vanflyta)

Indications：Quizartinib specifically targets the FLT3-ITD mutant protein, blocking downstream MAPK/ERK···

WhatsApp
Official Service

Dosage and Administration of Quizartinib

Quizartinib is administered orally. The specific dosage is not fixed and varies over time based on the phase of treatment, electrocardiogram (ECG) res···【More】
Update: 29 Sep,2026Source: BigbearViews: 165
Quizartinib Dosage Guidelines

However, adherence to prescribed medication regimens directly impacts treatment efficacy and patient safety when using quizartinib. Patients should st···【More】
Update: 10 Apr,2026Source: BigbearViews: 199
Side Effects of Quizartinib

Quizartinib needs to be used in combination with chemotherapy and maintained long-term. During treatment, a range of treatment-related adverse reactio···【More】
Update: 10 Apr,2026Source: BigbearViews: 192
Indications for Quizartinib:

Quizartinib is a tyrosine kinase inhibitor (TKI) indicated for newly diagnosed adult patients with FLT3-ITD mutation-positive acute myeloid leukemia (···【More】
Update: 10 Apr,2026Source: BigbearViews: 193